Cao Y
Cell Biosci. 2024; 14(1):104.
PMID: 39164745
PMC: 11334496.
DOI: 10.1186/s13578-024-01282-w.
Kuburich N, Sabapathy T, Demestichas B, Maddela J, den Hollander P, Mani S
Semin Cancer Biol. 2023; 95:120-139.
PMID: 37572731
PMC: 10530624.
DOI: 10.1016/j.semcancer.2023.08.002.
Batarfi W, Mohd Yunus M, A Hamid A
Molecules. 2023; 28(6).
PMID: 36985625
PMC: 10058891.
DOI: 10.3390/molecules28062652.
Taiyab A, West-Mays J
Front Cell Dev Biol. 2022; 10:886053.
PMID: 35656546
PMC: 9152183.
DOI: 10.3389/fcell.2022.886053.
Cevatemre B, Ulukaya E, Dere E, Dilege S, Acilan C
Front Cell Dev Biol. 2022; 9:738916.
PMID: 35083212
PMC: 8785343.
DOI: 10.3389/fcell.2021.738916.
Nc886 promotes renal cancer cell drug-resistance by enhancing EMT through Rock2 phosphorylation-mediated β-catenin nuclear translocation.
Gao W, Zhang S, Guorong L, Liu Q, Zhu A, Gui F
Cell Cycle. 2022; 21(4):340-351.
PMID: 34974812
PMC: 8855853.
DOI: 10.1080/15384101.2021.2020431.
Rab31-dependent regulation of transforming growth factor ß expression in breast cancer cells.
Soelch S, Beaufort N, Loessner D, Kotzsch M, Reuning U, Luther T
Mol Med. 2021; 27(1):158.
PMID: 34906074
PMC: 8670132.
DOI: 10.1186/s10020-021-00419-8.
Epithelial to Mesenchymal Transition History: From Embryonic Development to Cancers.
Lachat C, Peixoto P, Hervouet E
Biomolecules. 2021; 11(6).
PMID: 34067395
PMC: 8224685.
DOI: 10.3390/biom11060782.
Quantitative Chemical Proteomics Reveals Resveratrol Inhibition of A549 Cell Migration Through Binding Multiple Targets to Regulate Cytoskeletal Remodeling and Suppress EMT.
Chen X, Wang Y, Tian J, Shao Y, Zhu B, Wang J
Front Pharmacol. 2021; 12:636213.
PMID: 33867987
PMC: 8044895.
DOI: 10.3389/fphar.2021.636213.
Inhibition of Rho kinase suppresses capsular contraction following lens injury in mice.
Ichikawa K, Tanaka S, Miyajima M, Okada Y, Saika S
Taiwan J Ophthalmol. 2020; 10(2):100-105.
PMID: 32874837
PMC: 7442104.
DOI: 10.4103/tjo.tjo_80_19.
Optical coherence tomography for imaging of endocardial to mesenchymal transition during avian heart development.
Courchaine K, Rugonyi S
Biomed Opt Express. 2019; 10(11):5989-5995.
PMID: 31799059
PMC: 6865111.
DOI: 10.1364/BOE.10.005989.
Animal Models for Heart Valve Research and Development.
Kheradvar A, Zareian R, Kawauchi S, Goodwin R, Rugonyi S
Drug Discov Today Dis Models. 2019; 24:55-62.
PMID: 30631375
PMC: 6322555.
DOI: 10.1016/j.ddmod.2018.04.001.
A Potential Link Between Oxidative Stress and Endothelial-to-Mesenchymal Transition in Systemic Sclerosis.
Thuan D, Zayed H, Eid A, Abou-Saleh H, Nasrallah G, Mangoni A
Front Immunol. 2018; 9:1985.
PMID: 30283435
PMC: 6156139.
DOI: 10.3389/fimmu.2018.01985.
TAK1 activation of alpha-TAT1 and microtubule hyperacetylation control AKT signaling and cell growth.
Shah N, Kumar S, Zaman N, Pan C, Bloodworth J, Lei W
Nat Commun. 2018; 9(1):1696.
PMID: 29703898
PMC: 5923212.
DOI: 10.1038/s41467-018-04121-y.
Formin-dependent TGF-β signaling for epithelial to mesenchymal transition.
Rana M, Aloisio F, Choi C, Barber D
Mol Biol Cell. 2018; 29(12):1465-1475.
PMID: 29668357
PMC: 6014098.
DOI: 10.1091/mbc.E17-05-0325.
Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner.
Sheta R, Wang Z, Bachvarova M, Plante M, Gregoire J, Renaud M
Oncotarget. 2017; 8(47):82506-82530.
PMID: 29137281
PMC: 5669907.
DOI: 10.18632/oncotarget.19714.
Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration.
Hachim I, Villatoro M, Canaff L, Hachim M, Boudreault J, Haiub H
Sci Rep. 2017; 7(1):14976.
PMID: 29101386
PMC: 5670207.
DOI: 10.1038/s41598-017-14549-9.
Runx2-I is an Early Regulator of Epithelial-Mesenchymal Cell Transition in the Chick Embryo.
Tavares A, Brown J, Ulrich E, Dvorak K, Runyan R
Dev Dyn. 2017; 247(3):542-554.
PMID: 28631378
PMC: 5736463.
DOI: 10.1002/dvdy.24539.
Genetic and flow anomalies in congenital heart disease.
Rugonyi S
AIMS Genet. 2017; 3(3):157-166.
PMID: 28480330
PMC: 5417695.
DOI: 10.3934/genet.2016.3.157.
HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.
Nami B, Wang Z
Cancers (Basel). 2017; 9(5).
PMID: 28445439
PMC: 5447950.
DOI: 10.3390/cancers9050040.